相关实验视频
Updated: Jul 1, 2026

16:11
Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
植入式心脏转换器-除器冲击器后患者的评估和管理
Anil K Gehi1, Davendra Mehta, J Anthony Gomes
1Division of Cardiology, Emory University School of Medicine, Atlanta, Ga, USA. anilgehi@gmail.com
JAMA
|December 21, 2006
概括
管理可植入式心脏转换器-除器 (ICD) 冲击涉及编程和抗失常药物. 这些策略可以减少ICD的冲击,同时保持设备对心脏病患者的救生功能.
科学领域:
- 心脏病学 心脏病学
- 医疗器械 医疗器械
- 电子生理学 电子生理学
背景情况:
- 植入式心脏变压器 (ICD) 越来越多地用于降低心脏病患者的死亡率.
- 非电生理学家经常管理患有ICD冲击的患者.
研究的目的:
- 评估ICD冲击患者的管理策略.
- 确定ICD冲击事件的评估和治疗的选择.
主要方法:
- 使用PubMed和MEDLINE (1990-2006) 进行了全面的文献搜索.
- 相关的关键词包括"除器,可植入","抗不律性药物"和"心跳骤停治疗".
- 还审查了主要心脏病学组织的指导方针.
主要成果:
- 无论是适当的还是不适当的ICD冲击,都会对患者的生活质量产生负面影响.
- ICD编程技术可以有效地减少冲击事件的发生.
- 抗心律失常药物为减少冲击频率提供了一种可行的方法.
结论:
- 有效的ICD编程和抗心律失常药物可以减少冲击事件.
- 这些干预措施有助于保持ICDs的治疗效益.
- 了解管理选择对于经历ICD冲击的患者至关重要.
相关概念视频
Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation IV: Nursing Management
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Endocarditis III: Medical Management
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

